Monday, 16 July 2018 - 13:32
  • it
  • de
  • en
  • fr

Biotest AG

Losses in H1 for Germany-based Biotest

Germany-based Biotest reported losses over the first semester of 2017. Biotest manufactures and markets products based on plasma proteins for clinical immunology. It had to recall batches of albumin products over the first six months of 2017, since they caused…

Germany’s Biotest AG sold to Chinese investor Creat for €1.3bn

After surprisingly quick talks, Chinese investor Creat Group acquired Germany’s Biotest, valuing it €1.3bn including debt. As part of the complex agreement, ordinary shares are valued €28.5 and preference shares are valued €19. The pivot of the negotiation is the…

Chinese investor to offer €1.2bn for Germany’s Biotest AG

Chinese investor Creat Group Corp offered €1.2bn for German biotech company Biotest AG, including debt. Biotest focuses in the hematology/hemophilia and clinical immunology treatment areas and is headed by CEO Bernhard Ehmer. The group currently has 2,500 employees and a…